Korro Bio, Inc. (KRRO)
11.16
-0.25
(-2.19%)
USD |
NASDAQ |
Mar 19, 15:34
Korro Bio EPS Diluted (Quarterly) : -5.321 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cencora, Inc. | 2.865 |
| BioCryst Pharmaceuticals, Inc. | 1.121 |
| United Therapeutics Corp. | 7.702 |
| Collegium Pharmaceutical, Inc. | 0.4604 |
| ProKidney Corp. | -0.122 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.04M |
| Revenue (Quarterly) | 1.292M |
| Total Expenses (Quarterly) | 51.33M |
| Enterprise Value | 80.52M |
| Gross Profit Margin (Quarterly) | 49.77% |
| Profit Margin (Quarterly) | -3.87K% |
| Earnings Yield | -111.8% |
| Normalized Earnings Yield | -88.82 |